209 related articles for article (PubMed ID: 21596316)
1. Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.
Zwang Y; Sas-Chen A; Drier Y; Shay T; Avraham R; Lauriola M; Shema E; Lidor-Nili E; Jacob-Hirsch J; Amariglio N; Lu Y; Mills GB; Rechavi G; Oren M; Domany E; Yarden Y
Mol Cell; 2011 May; 42(4):524-35. PubMed ID: 21596316
[TBL] [Abstract][Full Text] [Related]
2. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
[TBL] [Abstract][Full Text] [Related]
3. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.
Fang L; Li G; Liu G; Lee SW; Aaronson SA
EMBO J; 2001 Apr; 20(8):1931-9. PubMed ID: 11296226
[TBL] [Abstract][Full Text] [Related]
4. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
Tandon M; Chen Z; Pratap J
J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
[TBL] [Abstract][Full Text] [Related]
5. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
6. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
7. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
8. Benzo(a)pyrene-caused increased G1-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblasts.
Jiao S; Liu B; Gao A; Ye M; Jia X; Zhang F; Liu H; Shi X; Huang C
Toxicol Lett; 2008 May; 178(3):167-75. PubMed ID: 18448277
[TBL] [Abstract][Full Text] [Related]
9. Avian Reovirus Protein p17 Functions as a Nucleoporin Tpr Suppressor Leading to Activation of p53, p21 and PTEN and Inactivation of PI3K/AKT/mTOR and ERK Signaling Pathways.
Huang WR; Chiu HC; Liao TL; Chuang KP; Shih WL; Liu HJ
PLoS One; 2015; 10(8):e0133699. PubMed ID: 26244501
[TBL] [Abstract][Full Text] [Related]
10. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner.
Choudhuri T; Pal S; Das T; Sa G
J Biol Chem; 2005 May; 280(20):20059-68. PubMed ID: 15738001
[TBL] [Abstract][Full Text] [Related]
11. K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner.
Zundler S; Caioni M; Müller M; Strauch U; Kunst C; Woelfel G
PLoS One; 2016; 11(1):e0147736. PubMed ID: 26824610
[TBL] [Abstract][Full Text] [Related]
12. EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.
Tarcic G; Avraham R; Pines G; Amit I; Shay T; Lu Y; Zwang Y; Katz M; Ben-Chetrit N; Jacob-Hirsch J; Virgilio L; Rechavi G; Mavrothalassitis G; Mills GB; Domany E; Yarden Y
FASEB J; 2012 Apr; 26(4):1582-92. PubMed ID: 22198386
[TBL] [Abstract][Full Text] [Related]
13. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells.
Jiang Q; Zhou C; Bi Z; Wan Y
J Ocul Pharmacol Ther; 2006 Apr; 22(2):93-102. PubMed ID: 16722795
[TBL] [Abstract][Full Text] [Related]
14. The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability.
Nam HJ; Chae S; Jang SH; Cho H; Lee JH
Carcinogenesis; 2010 Sep; 31(9):1531-40. PubMed ID: 20584748
[TBL] [Abstract][Full Text] [Related]
15. [The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to gamma-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7].
Zheng L; Ren JQ; Chen Q; Zhang HP; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):594-7. PubMed ID: 15634518
[TBL] [Abstract][Full Text] [Related]
16. p53 response to arsenic exposure in epithelial cells: protein kinase B/Akt involvement.
Sandoval M; Morales M; Tapia R; del Carmen Alarcón L; Sordo M; Ostrosky-Wegman P; Ortega A; López-Bayghen E
Toxicol Sci; 2007 Sep; 99(1):126-40. PubMed ID: 17567589
[TBL] [Abstract][Full Text] [Related]
17. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.
DiRenzo J; Signoretti S; Nakamura N; Rivera-Gonzalez R; Sellers W; Loda M; Brown M
Cancer Res; 2002 Jan; 62(1):89-98. PubMed ID: 11782364
[TBL] [Abstract][Full Text] [Related]
18. Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
Lee CC; Lin ML; Meng M; Chen SS
Anticancer Res; 2018 Mar; 38(3):1377-1389. PubMed ID: 29491062
[TBL] [Abstract][Full Text] [Related]
19. Disentangling Pro-mitotic Signaling during Cell Cycle Progression using Time-Resolved Single-Cell Imaging.
Benary M; Bohn S; Lüthen M; Nolis IK; Blüthgen N; Loewer A
Cell Rep; 2020 Apr; 31(2):107514. PubMed ID: 32294432
[TBL] [Abstract][Full Text] [Related]
20. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
LeVea CM; Reeder JE; Mooney RA
Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
